Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
Titel:
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
Auteur:
Brandes, Alba A. Tosoni, A. Franceschi, E. Blatt, V. Santoro, A. Faedi, M. Amistà , P. Gardiman, M. Labianca, R. Bianchini, C. Ermani, M. Reni, M.